Symphysiolysis: Acupuncture Therapeutic Benefits: a Randomized Placebo Controlled Study.
NCT ID: NCT04471285
Last Updated: 2022-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2018-07-01
2021-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
the investigators evaluate the effect of the acupuncture on the pain and the ability of the pregnant patient.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture for Back and Neck Pain in an Emergency Room Setting
NCT00859365
Group Acupuncture for Pain
NCT02328586
Acupuncture Therapy in Patients With Subacromial Impingement Syndrome
NCT05794633
Sinew Acupuncture for Neck Pain: Randomized Controlled Trial
NCT02834702
Acupuncture for Treatment of Chronic LBP, RCT, Single Blinded
NCT00353847
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Examine for pain or sensitivity to touch on pubic symphysis joint.
* Modified Trendelenburg's test
* Active straight leg raise test The trial doctor will mark the woman's chart with a continuous number that will become her number in the trial, and she will then be referred to the acupuncturist.
Women will be randomly divided at a 1:1 ratio, according to the randomized number chart prepared by the trial's statistician. The list of random numbers will be delivered to the head of the acupuncturist team and it will be the only copy in existence aside from the one belonging to the statistician. According to that list of numbers, the head acupuncturist will instruct the acupuncturist on call as to the type of acupuncture to be performed, true (V) vs. placebo (P) on the participant . The type of acupuncture (V or P) will be recorded in the woman's chart.
The treatment will be conducted by one of the acupuncturists on staff at the integrative medical center. All the acupuncturists have many years of experience in treating pregnant women with Chinese medicine. The acupuncture will be carried out with 0.18/40mm single use needles. Point selection and numbers of points used will be determined following the evaluation of the acupuncturist according to the accepted standards of in Chinese medicine. They will not, however, deviate from the list of true acupuncture points in the list of possible true paints . Placebo acupuncture will be three to four points selected at random from the list of placebo points . The acupuncturist's evaluation in the placebo group will be the same as in the evaluation in the treatment group and the true acupuncture points selected during that time will be the ones used in case of failure and continued pain following the first (placebo) treatment, after cross over.
It should be noted that the woman's assessment and the exam will take place before the acupuncture treatment begins, whether it is the true or placebo group.
Approximately 30 minutes after the acupuncture treatment began, the woman will be asked once again to assess her level of pain. An improvement of 1.5 marks on the NRS scale is considered a positive response. Women whose response after 30 minutes of acupuncture is less than this will be given the opposite acupuncture treatment. Those who received V acupuncture will receive P acupuncture and those who received P acupuncture will receive V acupuncture. A woman will be called our team if her pain is significantly worse. She will then receive the treatment that has been found most effective between the two acupuncture treatments she received previously.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
true acupuncture
patient will get treatment according to the point the will help the symphysiolysis according to the Alternative medicine
acupuncture
acupuncture
Sham acupuncture
patient will get treatment according to the point the will NOT help the symphysiolysis according to the Alternative medicine
Sham acupuncture
Sham acupuncture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acupuncture
acupuncture
Sham acupuncture
Sham acupuncture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Single embryo pregnancy in week 24-42
* was diagnosed with symphysiolisis according to written above
* Pain/sensitivity \>5 on NRS scale in symphysis pubis area for more than two weeks
Exclusion Criteria
* Pain from a different source
* pelvic bone disease or history of severe pelvic bone injury
* Thrombocytopenia (plt\<50.000)
* Acupuncture treatment is contraindicated
* High risk pregnancy
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shaare Zedek Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
jaffea
OBGYN resident, MD MPH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Menachem Oberbaum, MD
Role: PRINCIPAL_INVESTIGATOR
head of alternative medicine
Sorina Grisaro, MD PhD
Role: STUDY_DIRECTOR
head of OBGYN department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shari Zedek Medical Center
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0115-18-SZMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.